At a glance
ClinicalIndex Comparison RecordN/AActive· 284 enrolled
Drug / intervention
PBI Radiotherapy 6 Gy +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prone Partial Breast Irradiation (PBI): A Prospective Randomized Trial Comparing Five Versus Three Fractions
In Brief
A clinical study evaluating PBI Radiotherapy 6 Gy and PBI Radiotherapy 8 Gy for Breast Cancer. Active but no longer recruiting, targeting 284 participants across 1 site.
Detailed Summary
The purpose of this study is to test whether a radiotherapy regimen of 8 GY x 3 days over 5 days (every other day) is as safe (well-tolerated) and effective as 6 Gy x 5 over five consecutive days
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/AActive
2015201620172018201920202021202220232024202520262027
First PostedOct 2014
Enrollment StartOct 2014
Primary CompletionDec 2023
TodayJul 2026
Study CompletionDec 2026
First PostedOct 28, 2014
Enrollment StartOct 28, 2014
Primary CompletionDec 7, 2023
Study CompletionDec 7, 2026
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 11.7 years ago
Interventions
PBI Radiotherapy 6 Gyradiation
Patients will receive 3D-Conformal or Intensity Modulated Radiation Therapy (IMRT) of 6 Gy x 5, over 5 consecutive days
PBI Radiotherapy 8 Gyradiation
Patients will receive 3D-Conformal or Intensity Modulated Radiation Therapy (IMRT) of 8 Gy x 3, over 5 days, every other day